Anal Squamous Cell Carcinoma — Trials

Anal Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

51 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 24
Recruiting: 13
Ph III recruiting: 1
Growth YoY: —
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3)

clinicaltrialsPublishedShowing 51–51 of 51 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02162641	Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer(R-SeNSAR)	withdrawn	—	0	The Christie NHS Foundation TrustOTHER	0	Jun 3, 2015	clinicaltrials